Explore a rare case of systemic mastocytosis in a young adult, highlighting its role in unexplained osteoporosis and the need ...

Systemic Mastocytosis with an Associated Hematologic Neoplasm SM-AHN is a rare subtype in which systemic mastocytosis coexists with another health condition, such as acute myeloid leukemia (AML ...

Systemic mastocytosis is a rare blood disorder in which too many mast cells accumulate in various parts of the body. Advanced forms of systemic mastocytosis have more significant symptoms and in ...

—In a study of 116 patients with systemic mastocytosis (SM), a rare mast cell disease, about 1 in 5 participants progressed to an advanced form of SM, incurring greater healthcare costs along ...

A new case report was published in Oncoscience's Volume 12 on February 4, 2025, titled “Breaking point: Systemic mastocytosis manifesting as severe osteoporosis.” ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window In a study of 116 patients with systemic mastocytosis (SM), a rare mast cell disease, about 1 in 5 participants ...

This report highlights the diagnostic challenges of SM, emphasize its underrecognized role in osteoporosis and fragility fractures, and advocates for ...

Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically ...

Blueprint Medicines Corporation, a Delaware-based biopharmaceutical company, recently released its financial results for the year ended December 31, 2024, along with key business highlights. The ...